

Trump's Most Favored Nation Pricing | Dr. David Bearss
In this solo episode, Dr. Bearss breaks down the controversial “Most Favored Nation” (MFN) drug pricing rule introduced during the Trump administration. What is the policy aiming to solve? How would it change the cost of prescription drugs in the U.S.? And why did it stir such intense debate across the healthcare and pharmaceutical industries?
With clear, research-backed insight, David explores the economic and political implications of MFN, how it compares to international drug pricing models, and what it tells us about the future of healthcare reform in America.
Whether you’re in healthcare, policy, or just trying to make sense of why your prescriptions cost so much, this is a must-listen.
Sponsors
BioHive: https://www.biohive.com/
Galvan: https://www.galvan.health/
Follow Good Medicine Podcast
Insta: https://www.instagram.com/good.medicine.podcast/ X: https://x.com/GoodMedicinePod
TikTok: https://www.tiktok.com/@good.medicine.podcast LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/